Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites

Transcription factors (TFs) bind to thousands of DNA sequences in mammalian genomes, but most of these binding events appear to have no direct effect on gene expression. It is unclear why only a subset of TF bound sites are actively involved in transcriptional regulation. Moreover, the key genomic features that accurately discriminate between active and inactive TF binding events remain ambiguous. Recent studies have identified promoter-distal RNA polymerase II (RNAP2) binding at enhancer elements, suggesting that these interactions may serve as a marker for active regulatory sequences. Despite these correlative analyses, a thorough functional validation of these genomic co-occupancies is still lacking. To characterize the gene regulatory activity of DNA sequences underlying promoter-distal TF binding events that co-occur with RNAP2 and TF sites devoid of RNAP2 occupancy using a functional reporter assay, we performed cis-regulatory element sequencing (CRE-seq). We tested more than 1000 promoter-distal CCAAT/enhancer-binding protein beta (CEBPB)-bound sites in HepG2 and K562 cells, and found that CEBPB-bound sites co-occurring with RNAP2 were more likely to exhibit enhancer activity. CEBPB-bound sites further maintained substantial cell-type specificity, indicating that local DNA sequence can accurately convey cell-type-specific regulatory information. By comparing our CRE-seq results to a comprehensive set of genome annotations, we identified a variety of genomic features that are strong predictors of regulatory element activity and cell-type-specific activity. Collectively, our functional assay results indicate that RNAP2 occupancy can be used as a key genomic marker that can distinguish active from inactive TF bound sites.

[1]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[2]  C. Glass,et al.  Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation , 2013, Nature.

[3]  Richard M Myers,et al.  Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. , 2009, Genome research.

[4]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[5]  Nathaniel D. Heintzman,et al.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.

[6]  A. Visel,et al.  ChIP-seq accurately predicts tissue-specific activity of enhancers , 2009, Nature.

[7]  B. Oostra,et al.  A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. , 2003, Human molecular genetics.

[8]  André L. Martins,et al.  Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers , 2014, Nature Genetics.

[9]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[10]  Joseph B Hiatt,et al.  Massively parallel functional dissection of mammalian enhancers in vivo , 2012, Nature Biotechnology.

[11]  Manolis Kellis,et al.  Discovery and characterization of chromatin states for systematic annotation of the human genome , 2010, Nature Biotechnology.

[12]  M. Levine Transcriptional Enhancers in Animal Development and Evolution , 2010, Current Biology.

[13]  Junling Wang,et al.  GABP transcription factor is required for myeloid differentiation, in part, through its control of Gfi-1 expression. , 2010, Blood.

[14]  Barak A. Cohen,et al.  Complex effects of nucleotide variants in a mammalian cis-regulatory element , 2012, Proceedings of the National Academy of Sciences.

[15]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[16]  Timothy L. Bailey,et al.  Gene expression Advance Access publication May 4, 2011 DREME: motif discovery in transcription factor ChIP-seq data , 2011 .

[17]  D. Ramji,et al.  CCAAT/enhancer-binding proteins: structure, function and regulation. , 2002, The Biochemical journal.

[18]  E. Liu,et al.  An Oestrogen Receptor α-bound Human Chromatin Interactome , 2009, Nature.

[19]  Dan Xie,et al.  Extensive Variation in Chromatin States Across Humans , 2013, Science.

[20]  J. Ragoussis,et al.  A Large Fraction of Extragenic RNA Pol II Transcription Sites Overlap Enhancers , 2010, PLoS biology.

[21]  G. Sumara,et al.  c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. , 2006, Genes & development.

[22]  Jing-Dong J Han,et al.  Evolution of Alu elements toward enhancers. , 2014, Cell reports.

[23]  T. Mikkelsen,et al.  Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. , 2013, Genome research.

[24]  Richard M Myers,et al.  Mapping genome-wide transcription factor binding sites in frozen tissues , 2013, Epigenetics & Chromatin.

[25]  Genevieve Konopka,et al.  HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells , 2011, Development.

[26]  Leighton J. Core,et al.  Coordinated Effects of Sequence Variation on DNA Binding, Chromatin Structure, and Transcription , 2013, Science.

[27]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[28]  Jennifer Doudna,et al.  RNA-programmed genome editing in human cells , 2013, eLife.

[29]  Daofeng Li,et al.  Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2 , 2015, EMBO reports.

[30]  Philip Cayting,et al.  An encyclopedia of mouse DNA elements (Mouse ENCODE) , 2012, Genome Biology.

[31]  M. Groudine,et al.  Functional and Mechanistic Diversity of Distal Transcription Enhancers , 2011, Cell.

[32]  Tom Maniatis,et al.  Transcriptional activation: A complex puzzle with few easy pieces , 1994, Cell.

[33]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[34]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[35]  Timothy J. Durham,et al.  "Systematic" , 1966, Comput. J..

[36]  Noboru Jo Sakabe,et al.  Transcriptional enhancers in development and disease , 2012, Genome Biology.

[37]  Genevieve Konopka,et al.  HNF 4 A is essential for specification of hepatic progenitors from human pluripotent stem cells , 2022 .

[38]  Gary D. Stormo,et al.  Identification of consensus patterns in unaligned DNA sequences known to be functionally related , 1990, Comput. Appl. Biosci..

[39]  Francesca Chiaromonte,et al.  Erythroid GATA 1 function revealed by genome-wide analysis of transcription factor occupancy , histone modifications , and mRNA expression , 2009 .

[40]  Zhigang Zhang,et al.  Latent KSHV infection increases the vascular permeability of human endothelial cells. , 2011, Blood.

[41]  Raja Jothi,et al.  GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells. , 2011, Blood.

[42]  A. Mortazavi,et al.  Genome-Wide Mapping of in Vivo Protein-DNA Interactions , 2007, Science.

[43]  C. Danko,et al.  Enhancer transcripts mark active estrogen receptor binding sites , 2013, Genome research.

[44]  Richard M Myers,et al.  Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner , 2012, Genome research.

[45]  B. Cohen,et al.  Massively parallel in vivo enhancer assay reveals that highly local features determine the cis-regulatory function of ChIP-seq peaks , 2013, Proceedings of the National Academy of Sciences.

[46]  B. Cohen,et al.  High-throughput functional testing of ENCODE segmentation predictions , 2014, Genome research.

[47]  C. Glass,et al.  Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription , 2013, Nature.

[48]  J. Weitzman,et al.  JunD Protects the Liver from Ischemia/Reperfusion Injury by Dampening AP-1 Transcriptional Activation* , 2008, Journal of Biological Chemistry.

[49]  Jonathan K. Pritchard,et al.  Identification of Genetic Variants That Affect Histone Modifications in Human Cells , 2013, Science.